Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide banner announces an NIH terminology transition, saying agencies are using “Super Intelligence” instead of “Artificial Intelligence” and linking to transition updates.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check44 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the expected trial details with an access-restricted notice. This indicates a blockage rather than a modification of the study information.SummaryDifference18%

- Check65 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6. This indicates a new version of the study details page rather than a substantive change to the study data.SummaryDifference0.0%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.